Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Stansky Michael P
Over the trailing 90 days, Stansky Michael P (Director at TriSalus Life Sciences, Inc.) bought $1.5M of stock in TLSI, per 5 SEC Form 4 transactions.
- Role
- Director
- Companies
- TLSI
- Window
- Trailing 90 days · 5 transactions · CIK 1424204
- Net activity
- +$1.5M ($1.5M bought · $0 sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | 5 | $1.5M | — | $1.5M |
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-05-15 | TLSI | Buy | 200.0K | $500K | Open market or private purchase |
| 2026-05-15 | TLSI | Buy | 410.0K | $1.0M | Open market or private purchase |
| 2026-05-14 | TLSI | Buy | 20.1K | $0 | Grant, award or other acquisition |
| 2026-05-14 | TLSI | Buy | 23.5K | $0 | Grant, award or other acquisition |
| 2026-05-14 | TLSI | Buy | 47.0K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Stansky's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.